Investigation of angiogenesis and epithelial-mesenchymal transition markers (CD31, VEGF, and E-Cadherin) in prostatic cancer patients: a multi-omics study.

Shahshenas S, Jalali Nadoushan M, Yarmohammadi H, Soltanipur M

Open source

DOI
10.1186/s12957-026-04379-3
Published
2026 Apr 25
Container
World journal of surgical oncology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12957-026-04379-3,
  title = {Investigation of angiogenesis and epithelial-mesenchymal transition markers (CD31, VEGF, and E-Cadherin) in prostatic cancer patients: a multi-omics study.},
  author = {Shahshenas S and Jalali Nadoushan M and Yarmohammadi H and Soltanipur M},
  year = {2026},
  journal = {World journal of surgical oncology},
  doi = {10.1186/s12957-026-04379-3},
  url = {https://doi.org/10.1186/s12957-026-04379-3}
}

RIS

TY  - JOUR
TI  - Investigation of angiogenesis and epithelial-mesenchymal transition markers (CD31, VEGF, and E-Cadherin) in prostatic cancer patients: a multi-omics study.
AU  - Shahshenas S
AU  - Jalali Nadoushan M
AU  - Yarmohammadi H
AU  - Soltanipur M
PY  - 2026
JO  - World journal of surgical oncology
DO  - 10.1186/s12957-026-04379-3
UR  - https://doi.org/10.1186/s12957-026-04379-3
ER  - 

APA

S, S., M, J. N., H, Y., & M, S. (2026). Investigation of angiogenesis and epithelial-mesenchymal transition markers (CD31, VEGF, and E-Cadherin) in prostatic cancer patients: a multi-omics study.. World journal of surgical oncology. https://doi.org/10.1186/s12957-026-04379-3

Source records